Over 100 startups met with 25 UK and European corporations and investors during the Meet and Pitc...
Have you heard of NGT3? THE fund for entrepreneurs in the life sciences and medical devices field
NGT3 is a venture fund that holds a technology incubator that encourages, supports, and invests in innovation-based technologies and entrepreneurs, primarily in the areas of life sciences and medical devices.
Strategically located in Nazareth, NGT3 benefits from the untapped potential of scientists and researchers in the Arab sector while being fully integrated into Israel’s world-renowned technological creativity and entrepreneurial ecosystem.
NGT3’s team are hands-on investors, involved in all aspects of their portfolio companies with the target of value creation. They support the projects in all the relevant aspects such as: technology and clinical development, marketing and business development, building of team and management, creating IP and regulatory strategy.
Their entrepreneurs truly feel “at home” at NGT3. They benefit from the input and guidance of the professional management team, enjoy the friendly atmosphere, and find inspiration in the multicultural environment.
Some of the companies that NGT3 has invested in are:
PlasFree founded by, Prof. Abed Higazi, a leading expert in the field of biochemistry and the head of the Division of Laboratories & Department of Clinical Biochemistry, Hadassah university Hospital. PlasFree founded Clearplasma, a device that modifies human plasma to improve the treatment of massive bleeding and bleeding disorders.Prof. Abd-al Roof Hijazi also founded PamBio, an innovative biotechnology company developing the only known drug therapy for the treatment of haemorrhagic stroke.
Nurami co-founded by Nora Nseir who is a biomedical engineer expert with extensive experience in Nano-biomaterials. Nurami develops smart nano-fiber technologies for surgical use and soft tissue repair
Elgan Pharma develops a technology targeted at prevention of visual impairment in preterm infants, ELgan was co-founded by Dr. Taher Nassar senior researcher at the Hebrew University, with a Ph.D. and postdoctoral in Pharmaceutical Sciences and Drug Delivery Designing both from the Hebrew University of Jerusalem.
The ArabtechPort team attended an event on September 10 organized by Matrix, and hosted by Nazare...
The third edition of the Peres Heritage Initiative took stage during the session: “The Good News:...